يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Newly glioblastoma"', وقت الاستعلام: 1.73s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma

    المؤلفون: Kenichiro Asano, Toshio Fumoto, Masashi Matsuzaka, Seiko Hasegawa, Naoya Suzuki, Kenichi Akasaka, Kosuke Katayama, Akihisa Kamataki, Akira Kurose, Hiroki Ohkuma

    المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)

    مصطلحات موضوعية: Newly glioblastoma, Combination therapy, Temozolomide, Interferon-β, MGMT, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1471-2407

    URL الوصول: https://doaj.org/article/5b023ed7c6704ada8d1a2efdb4981596

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma

    المؤلفون: Asano, KenichiroAff1, Fumoto, Toshio, Matsuzaka, MasashiAff2, Aff3, Hasegawa, Seiko, Suzuki, Naoya, Akasaka, Kenichi, Katayama, Kosuke, Kamataki, Akihisa, Kurose, Akira, Ohkuma, Hiroki

    المصدر: BMC Cancer. 21(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma

    المؤلفون: Akihisa Kamataki, Naoya Suzuki, Kosuke Katayama, Kenichiro Asano, Akira Kurose, Hiroki Ohkuma, Toshio Fumoto, Seiko Hasegawa, Masashi Matsuzaka, Kenichi Akasaka

    المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
    BMC Cancer

    مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_treatment, Kaplan-Meier Estimate, 0302 clinical medicine, Maintenance therapy, Clinical endpoint, Promoter Regions, Genetic, DNA Modification Methylases, RC254-282, Aged, 80 and over, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Chemoradiotherapy, Middle Aged, Prognosis, Combined Modality Therapy, Treatment Outcome, 030220 oncology & carcinogenesis, Female, MGMT, medicine.drug, Research Article, Adult, medicine.medical_specialty, Vincristine, Combination therapy, Adolescent, Neutropenia, 03 medical and health sciences, Young Adult, Internal medicine, Genetics, medicine, Temozolomide, Humans, Aged, business.industry, Tumor Suppressor Proteins, DNA Methylation, medicine.disease, Radiation therapy, DNA Repair Enzymes, Interferon-β, business, Glioblastoma, 030217 neurology & neurosurgery, Newly glioblastoma

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6655d3abb8167d96d96cec49539a61b0
    https://doaj.org/article/5b023ed7c6704ada8d1a2efdb4981596

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء